Paolo Fundaro, Director at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 4,759 shares at $45.89 ($220K) on 2013-08-12, disclosed to the SEC on 2013-08-13.
Scheduled sale ($220k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.89 | 800 | $37K | 16.7% |
| 2 | $46.18 | 3,959 | $183K | 83.3% |
| Total | $46.13 avg | 4,759 | $220K | 100% |
| Filing → |
| ICPT | SELL | 2019-03-29 | $467K | — | Filing → |
| ICPT | SELL | 2015-07-24 | $166K | — | Filing → |
| ICPT | SELL | 2014-08-12 | $78K | — | Filing → |